自体脂肪移植市场
自体脂肪移植市场：2026年市场规模约为2.4305亿美元，2031年市场规模约为3.5218亿美元；预测期复合年增长率为7.70%；当前最大市场为北美；增长最快的市场为亚太地区。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
自体脂肪移植市场：2026年市场规模约为2.4305亿美元，2031年市场规模约为3.5218亿美元；预测期复合年增长率为7.70%；当前最大市场为北美；增长最快的市场为亚太地区。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 7.7% | 机构预测 |
| 市场规模 | 2026 | USD 243.05 million | 机构预测 |
| 市场规模 | 2031 | USD 352.18 million | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | breast augmentation | 2025 | 37.560% |
| end_user | hospitals | 2025 | 38.660% |
| geography | North America | 2025 | 42.440% |
关键结论
- application 维度中，breast augmentation 在 2025 年的公开份额为 37.56%。
- end_user 维度中，hospitals 在 2025 年的公开份额为 38.66%。
- geography 维度中，North America 在 2025 年的公开份额为 42.44%。
主要参与者
- AbbVie Inc.
- Alma Lasers Ltd.
- Emcyte Corporation
- Lipogems International S.p.A.
- Medikan International Inc.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Preference for autologous restoration and breast reconstruction | +1.800% | Global, concentrated in North America and Europe | Long term (≥ 4 years) |
| Body contouring after major weight loss | +1.000% | North America, with growth in South America | Medium term (2-4 years) |
| Use for scars, radiation injury, and soft-tissue defects | +0.700% | Global, with early gains in North America and EU research centers | Long term (≥ 4 years) |
| Closed-system processing and regenerative protocols | +0.900% | Global, with fastest adoption in North America and Asia-Pacific | Short term (≤ 2 years) |
| Improved closed-system fat processing and transfer workflows | +1.000% | North America, with growth in South America | Medium term (2-4 years) |
| Integration of fat grafting with regenerative and precision-aesthetic protocols | +0.700% | Global, with early gains in North America and EU research centers | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Variable retention and inconsistent processing protocols | -1.500% | Global, particularly acute in Asia-Pacific and South America | Long term (≥ 4 years) |
| Procedure cost, limited reimbursement, and svf regulation | -1.200% | North America and Western Europe | Medium term (2-4 years) |
| Surgeon-dependent outcomes and inconsistent processing protocols | -1.300% | Global, particularly acute in Asia-Pacific and South America | Long term (≥ 4 years) |
| Regulatory uncertainty around stromal vascular fraction and cell-enriched grafts | -1.700% | North America and Western Europe | Medium term (2-4 years) |
报告关注的关键问题
What is the projected value of autologous fat grafting by 2031?
The autologous fat grafting market is forecast to reach USD 352.18 million by 2031, growing at a 7.70% CAGR from 2026.
Which product category has the largest revenue share?
Integrated fat transfer systems held 35.45% of revenue in 2025 because facilities value combined harvesting, processing, and injection workflows.
Which application is growing fastest through 2031?
Buttock augmentation is projected to grow at an 8.80% CAGR through 2031, supported by demand for surgical volume restoration and the use of stronger safety protocols.
Why are hospitals important in autologous fat grafting?
Hospitals held 38.66% of revenue in 2025 because they provide complex oncoplastic care, breast reconstruction, and access to capital equipment.
Which region is forecast to grow the fastest?
Asia-Pacific is forecast to grow at a 10.88% CAGR through 2031, supported by private healthcare expansion, medical tourism, and aesthetic procedure demand.
What limits the wider use of autologous fat grafting?
Variable retention, repeat-procedure needs, limited coverage for elective care, and regulatory uncertainty around cell-enriched grafts can limit adoption.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence